関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Benzene, 1-bromo-3-(trifluoromethyl)- | HCID 9817 | — |
| 反応物 | (1S,4S)-2-Boc-2,5-diazabicyclo[2.2.1]heptane | HCID 11521263 | — |
| 試薬 | Sodium t-butoxide | HCID 23676156 | — |
| 触媒 | Binap, (A+-)- | HCID 634876 | — |
| 触媒 | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| 溶媒 | 1,4-Dioxane | HCID 31275 | — |
| 生成物 | Tert-butyl 5-[3-(trifluoromethyl)phenyl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate | HCID 67007430 | 92.96% |
反応手順
A 50 ml round bottom equipped with stir bar was charged with binap (0.146 g, 0.23 mmol) and TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (0.088 g, 0.10 mmol) dissolved in dioxane (5 mL). This was degassed and purged with nitrogen and stirred at RT for 10 mins. 1-bromo-3-(trifluoromethyl)benzene (0.323 g, 1.44 mmol) followed by tert-butyl 2,5-diazabicyclo[2.2.1]heptane-2-carboxylate (0.2 g, 0.96 mmol) and SODIUM TERT-BUTOXIDE (0.380 g, 3.83 mmol) were added, and the reaction was stirred at 80 °C for 2 hrs. The solution was diluted with EtOAc and washed with saturated NaHCO3 solution. The aqueous phase was extracted with EtOAc (3X20mL), combined, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude material was loaded on a Snap KP-SIL 25g column and purified on a Biotage SP4 instrument, eluting with 10% to 35% ethyl acetate in heptane to provide tert-butyl 5-(3-(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate (0.305 g, 93 %) as an oil.
情報源と証拠
| 出典データセット | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-19ca5beb727246179b7d4d2728f36d53 |
|---|
| 出典メモ | 750 AstraZeneca ELN dataset |
|---|